A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Clinical trial NCT05381909 · TERMINATED

Trial details

NCT number: NCT05381909
Sponsor: BeiGene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-07-06
Primary completion: 2025-07-25
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.